The Parkinson's disease-associated protein, Leucine-rich repeat kinase 2 (LRRK2), a known negative regulator of nuclear factor of activated T cells (NFAT), is expressed in myeloid cells such as macrophages and dendritic cells (DCs) and is involved in the host immune response against pathogens. Since, the Ca2+/NFAT/IL-2 axis has been previously found to regulate DC response to the fungus Aspergillus, we have investigated the role played by the kinase LRRK2 during fungal infection. Mechanistically, we found that in the early stages of the non-canonical autophagic response of DCs to the germinated spores of Aspergillus, LRRK2 undergoes progressive degradation and regulates NFAT translocation from the cytoplasm to the nucleus. Our results shed new light on the complexity of the Ca2+/NFAT/IL-2 pathway, where LRRK2 plays a role in controlling the immune response of DCs to Aspergillus.

Center for Translational Medicine St Anne's University Hospital Brno Brno Czechia

Department of Experimental Medicine University of Perugia Perugia Italy

National University of Singapore Graduate School for Integrative Sciences and Engineering National University of Singapore Singapore Singapore

Singapore Immunology Network Agency for Science Technology and Research Singapore Singapore

Toscana Life Sciences Foundation Siena Italy

Zobrazit více v PubMed

Paisán-Ruíz C, Jain S, Evans E, Gilks W, Simón J, van der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron (2004) 44(4):595–600. 10.1016/j.neuron.2004.10.023 PubMed DOI

Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol (2002) 51(3):296–301. 10.1002/ana.10113 PubMed DOI

Mata I, Wedemeyer W, Farrer M, Taylor J, Gallo K. LRRK2 in Parkinson’s disease: protein domains and functional insights. Trends Neurosci (2006) 29(5):286–93. 10.1016/j.tins.2006.03.006 PubMed DOI

Jorgensen N, Peng Y, Ho CC-Y, Rideout H, Petrey D, Liu P, et al. The WD40 domain is required for LRRK2 neurotoxicity. PLoS One (2009) 4(12):e8463. 10.1371/journal.pone.0008463 PubMed DOI PMC

Smith W, Pei Z, Jiang H, Moore D, Liang Y, West A, et al. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci U S A (2005) 102(51):18676–81. 10.1073/pnas.0508052102 PubMed DOI PMC

West A, Moore D, Choi C, Andrabi S, Li X, Dikeman D, et al. Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet (2007) 16(2):223–32. 10.1093/hmg/ddl471 PubMed DOI

Liu B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease. AAPS J (2006) 8(3):21. 10.1208/aapsj080369 PubMed DOI PMC

Whitton P. Inflammation as a causative factor in the aetiology of Parkinson’s disease. Br J Pharmacol (2007) 150(8):963–76. 10.1038/sj.bjp.0707167 PubMed DOI PMC

Gerlach OH, Winogrodzka A, Weber W. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review. Mov Disord (2011) 26(2):197–208. 10.1002/mds.23449 PubMed DOI PMC

Gardet AS, Benita Y, Li C, Sands B, Ballester I, Stevens C, et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 185(9):5577–85. 10.4049/jimmunol.1000548 PubMed DOI PMC

Hakimi M, Selvanantham T, Swinton E, Padmore R, Tong Y, Kabbach G, et al. Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm (Vienna) (2011) 118(5):795–808. 10.1007/s00702-011-0653-2 PubMed DOI PMC

Moehle M, Webber P, Tse T, Sukar N, Standaert D, DeSilva T, et al. LRRK2 inhibition attenuates microglial inflammatory responses. J Neurosci (2012) 32(5):1602–11. 10.1523/JNEUROSCI.5601-11.2012 PubMed DOI PMC

Gillardon F, Schmid R, Draheim H. Parkinson’s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience (2012) 208:41–8. 10.1016/j.neuroscience.2012.02.001 PubMed DOI

Kim B, Yang MS, Choi D, Kim JH, Kim HS, Seol W, et al. Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLoS One (2012) 7(4):e34693. 10.1371/journal.pone.0034693 PubMed DOI PMC

Liu Z, Lee J, Krummey S, Lu W, Cai H, Lenardo M. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol (2011) 12(11):1063–70. 10.1038/ni.2113 PubMed DOI PMC

Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol (2005) 5(6):472–84. 10.1038/nri1632 PubMed DOI

Liu W, Liu X, Li Y, Zhao J, Liu Z, Hu Z, et al. LRRK2 promotes the activation of NLRC4 inflammasome during PubMed DOI PMC

Goodridge HS, Simmons RM, Underhill DM. Dectin-1 stimulation by PubMed DOI

Fric J, Zelante T, Ricciardi-Castagnoli P. Phagocytosis of particulate antigens – all roads lead to calcineurin/NFAT signaling pathway. Front Immunol (2014) 4:513. 10.3389/fimmu.2013.00513 PubMed DOI PMC

Zelante T, Wong AY, Ping TJ, Chen J, Sumatoh HR, Viganò E, et al. CD103(+) dendritic cells control Th17 cell function in the lung. Cell Rep (2015) 12(11):1789–801. 10.1016/j.celrep.2015.08.030 PubMed DOI

Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 185(2):317–28. 10.1084/jem.185.2.317 PubMed DOI PMC

Graham JM. Isolation of lysosomes from tissues and cells by differential and density gradient centrifugation. Curr Protoc Cell Biol (2001) Chapter 3:Unit 3.6. 10.1002/0471143030.cb0306s07 PubMed DOI

Orenstein S, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci (2013) 16(4):394–406. 10.1038/nn.3350 PubMed DOI PMC

Schreij AM, Chaineau M, Ruan W, Lin S, Barker PA, Fon EA, et al. LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation. EMBO Rep (2015) 16(1):79–86. 10.15252/embr.201438714 PubMed DOI PMC

Alegre-Abarrategui J, Christian H, Lufino M, Mutihac R, Venda L, Ansorge O, et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet (2009) 18(21):4022–34. 10.1093/hmg/ddp346 PubMed DOI PMC

Pálfy M, Reményi A, Korcsmáros T. Endosomal crosstalk: meeting points for signaling pathways. Trends Cell Biol (2012) 22(9):447–56. 10.1016/j.tcb.2012.06.004 PubMed DOI PMC

Ma J, Becker C, Lowell C, Underhill D. Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II presentation of fungal-derived antigens. J Biol Chem (2012) 287(41):34149–56. 10.1074/jbc.M112.382812 PubMed DOI PMC

De Luca A, Iannitti R, Bozza S, Beau R, Casagrande A, D’Angelo C, et al. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. J Clin Invest (2012) 122(5):1816–31. 10.1172/JCI60862 PubMed DOI PMC

Martinez J, Malireddi RK, Lu Q, Cunha LD, Pelletier S, Gingras S, et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol (2015) 17(7):893–906. 10.1038/ncb3192 PubMed DOI PMC

Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, et al. Corticosteroids block autophagy protein recruitment in PubMed DOI PMC

Oikonomou V, Moretti S, Renga G, Galosi C, Borghi M, Pariano M, et al. Noncanonical fungal autophagy inhibits inflammation in response to IFN-gamma via DAPK1. Cell Host Microbe (2016) 20(6):744–57. 10.1016/j.chom.2016.10.012 PubMed DOI PMC

Hariri M, Millane G, Guimond MP, Guay G, Dennis JW, Nabi IR. Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell (2000) 11(1):255–68. 10.1091/mbc.11.1.255 PubMed DOI PMC

Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell (2010) 140(3):313–26. 10.1016/j.cell.2010.01.028 PubMed DOI PMC

Yu HB, Yurieva M, Balachander A, Foo I, Leong X, Zelante T, et al. NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation. Nucleic Acids Res (2015) 43(2):836–47. 10.1093/nar/gku1369 PubMed DOI PMC

Gade P, Manjegowda SB, Nallar SC, Maachani UB, Cross AS, Kalvakolanu DV. Regulation of the death-associated protein kinase 1 expression and autophagy via ATF6 requires apoptosis signal-regulating kinase 1. Mol Cell Biol (2014) 34(21):4033–48. 10.1128/MCB.00397-14 PubMed DOI PMC

Barrett J, Hansoul S, Nicolae D, Cho J, Duerr R, Rioux J, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet (2008) 40(8):955–62. 10.1038/ng.175 PubMed DOI PMC

Törkvist L, Halfvarson J, Ong R, Lördal M, Sjöqvist U, Bresso F, et al. Analysis of 39 Crohn’s disease risk loci in Swedish inflammatory bowel disease patients. Inflamm Bowel Dis (2010) 16(6):907–9. 10.1002/ibd.21105 PubMed DOI

Yun HJ, Kim H, Ga I, Oh H, Ho DH, Kim J, et al. An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. J Biochem (2015) 157(6):485–95. 10.1093/jb/mvv005 PubMed DOI

Gómez-Suaga P, Rivero-Ríos P, Fdez E, Blanca Ramírez M, Ferrer I, Aiastui A, et al. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum Mol Genet (2014) 23(25):6779–96. 10.1093/hmg/ddu395 PubMed DOI

Willingham A, Orth A, Batalov S, Peters E, Wen B, Aza-Blanc P, et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science (2005) 309(5740):1570–3. 10.1126/science.1115901 PubMed DOI

Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 18(2):630–9. 10.1158/1055-9965.EPI-08-0629 PubMed DOI

Yu P, Yan L, Zhang H, Lin X, Zhao X. Expression and clinical significance of sperm-associated antigen 9 in patients with endometrial carcinoma. Int J Gynecol Cancer (2012) 22(1):87–93. 10.1097/IGC.0b013e3182370f2e PubMed DOI

Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer (2009) 115(12):2671–83. 10.1002/cncr.24293 PubMed DOI

Garg M, Kanojia D, Suri S, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab (2009) 94(11):4613–8. 10.1210/jc.2009-0703 PubMed DOI

Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol (2011) 178(3):1009–20. 10.1016/j.ajpath.2010.11.047 PubMed DOI PMC

Behrens P, Brinkmann U, Wellmann A. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis (2003) 8(1):39–44. 10.1023/A:1021644918117 PubMed DOI

Hu WW, Wang ZB, Jiang ZZ, Qi ST, Huang L, Liang QX, et al. Scaffold subunit Aalpha of PP2A is essential for female meiosis and fertility in mice. Biol Reprod (2014) 91(1):19. 10.1095/biolreprod.114.120220 PubMed DOI

Porter IM, Schleicher K, Porter M, Swedlow JR. Bod1 regulates protein phosphatase 2A at mitotic kinetochores. Nat Commun (2013) 4:2677. 10.1038/ncomms3677 PubMed DOI PMC

Chien W, Sun QY, Lee KL, Ding LW, Wuensche P, Torres-Fernandez LA, et al. Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Mol Oncol (2015) 9(4):889–905. 10.1016/j.molonc.2015.01.002 PubMed DOI PMC

Woo CW, Kutzler L, Kimball SR, Tabas I. Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B. Nat Cell Biol (2012) 14(2):192–200. 10.1038/ncb2408 PubMed DOI PMC

Ory S, Zhou M, Conrads TP, Veenstra TD, Morrison DK. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol (2003) 13(16):1356–64. 10.1016/S0960-9822(03)00535-9 PubMed DOI

Fedida-Metula S, Feldman B, Koshelev V, Levin-Gromiko U, Voronov E, Fishman D. Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. Carcinogenesis (2012) 33(4):740–50. 10.1093/carcin/bgs021 PubMed DOI

Sontag J-MM, Sontag E. Protein phosphatase 2A dysfunction in Alzheimer’s disease. Front Mol Neurosci (2014) 7:16. 10.3389/fnmol.2014.00016 PubMed DOI PMC

Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A (2014) 111(3):1144–9. 10.1073/pnas.1322614111 PubMed DOI PMC

Nicola AM, Albuquerque P, Martinez LR, Dal-Rosso RA, Saylor C, Jesus M.De, et al. Macrophage autophagy in immunity to PubMed DOI PMC